Editas Medicine
EDIT
195 hedge funds and large institutions have $51M invested in Editas Medicine in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 61 reducing their positions, and 34 closing their positions.
97% more call options, than puts
Call options by funds: $668K | Put options by funds: $339K
6% less funds holding
Funds holding: 207 → 195 (-12)
8.81% less ownership
Funds ownership: 61.84% → 53.03% (-8.8%)
21% less capital invested
Capital invested by funds: $64.8M → $51M (-$13.8M)
28% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 61
32% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$2.1M |
| 2 |
Morgan Stanley
New York
|
+$1.65M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$1.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$946K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$822K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.62M |
| 2 |
Goldman Sachs
New York
|
-$1.79M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.65M |
| 4 |
MAM
Monaco Asset Management
Monaco
|
-$1.36M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.18M |
EDIT Hedge Fund Activity: Q1 2025 in Review
195 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2025, worth a combined $51M — down 21% from $64.8M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of EDIT and 23 opened new positions — a net loss of 11 holders — while 61 trimmed existing stakes and 44 added.
The largest buyer was UBS AM, adding an estimated $2.1M. The largest seller was Millennium Management, cutting an estimated $3.62M.
- 195 institutional investors held Editas Medicine (EDIT) as of Q1 2025, down from 207 in Q4 2024.
- Funds reported $51M of Editas Medicine stock for Q1 2025, down 21% quarter-over-quarter.
- 23 funds opened new Editas Medicine positions in Q1 2025 and 34 closed out, a net change of -11 holders.
- The largest Editas Medicine buyer in Q1 2025 was UBS AM, an estimated $2.1M added.
- The largest Editas Medicine seller in Q1 2025 was Millennium Management, an estimated $3.62M sold.
Based on aggregated 13F filings for Q1 2025.